Archive

Neovasc Announces Results for the Second Quarter of 2017

NASDAQ, TSX: NVCN VANCOUVER, Aug. 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced financial results for the second quarter ended June 30, 2017 (all figures in U.S. dollars unless otherwise indicated). "For both the Tiara and Reducer, the quarter saw consistent progress...

Read More

Neovasc to Host Second Quarter 2017 Conference Call

NASDAQ, TSX: NVCN VANCOUVER, Aug. 3, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that it will release its financial results for the second quarter 2017 on Thursday, August 10, 2017, after markets close. The Company will subsequently hold a conference call...

Read More

Neovasc Announces German Court Ruling

NASDAQ, TSX: NVCN VANCOUVER, June 16, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) reported today that the District Court in Munich, Germany has partially found in favour of Edwards Lifesciences Corporation (formerly CardiAQ Valve Technologies Inc.) ("CardiAQ"), in its case against...

Read More

Neovasc Tiara™ Featured in TVT 2017 Presentation

NASDAQ, TSX: NVCN VANCOUVER, June 15, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced its Tiara™ technology, developed to treat severe Mitral Regurgitation (MR), is being featured in a video recorded procedure to be presented at the 10th Annual Transcatheter...

Read More

Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

NASDAQ, TSX: NVCN VANCOUVER, June 13, 2017 /CNW/- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 13, 2017 in Vancouver, B.C. (the "Meeting")....

Read More

Neovasc to Present at JMP Securities Life Sciences Conference

NASDAQ, TSX: NVCN VANCOUVER, June 12, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) a specialty medical device company today announced that Alexei Marko, chief executive officer is scheduled to present at the JMP Securities Life Sciences Conference being held at the St....

Read More

Neovasc Announces Results for the First Quarter of 2017

NASDAQ, TSX: NVCN VANCOUVER, May 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced financial results for the first quarter ended March 31, 2017 (all figures in U.S. dollars unless otherwise indicated). "It was another quietly successful quarter," commented Neovasc CEO, Alexei...

Read More

Neovasc to Host First Quarter 2017 Conference Call

NASDAQ, TSX: NVCN VANCOUVER, May 1, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that it will release its financial results for the first quarter 2017 on Wednesday, May 10, 2017, after markets close. The Company will subsequently hold a conference call...

Read More